Delivery Order SPE2DB22D3016-SPE2DB25FAZN4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units, with a ceiling value of $9,728.17 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction supporting federal medical procurement needs. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with a completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of the company's pharmaceutical supply services to the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken and is part of the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 for Venclexta 100 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 on June 16, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a ceiling value of $9,728.17 and an ultimate completion date of June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAZN4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its capability to efficiently deliver specialized medications across multiple therapeutic domains, supporting critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 6/16/25 |